These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34688496)

  • 1. "I didn't feel like a number": The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings.
    Beharie N; Kaplan-Dobbs M; Urmanche A; Paone D; Harocopos A
    J Subst Abuse Treat; 2022 Jan; 132():108633. PubMed ID: 34688496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Access to Buprenorphine in Safety-Net Primary Care Clinics: The New York City Buprenorphine Nurse Care Manager Initiative.
    Kaplan-Dobbs M; Kattan JA; Tuazon E; Jimenez C; Saleh S; Kunins HV
    Am J Public Health; 2021 Feb; 111(2):215-218. PubMed ID: 33351661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.
    Jakubowski A; Rath C; Harocopos A; Wright M; Welch A; Kattan J; Navos Behrends C; Lopez-Castro T; Fox AD
    Harm Reduct J; 2022 Jul; 19(1):75. PubMed ID: 35818071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study.
    Kapadia SN; Griffin JL; Waldman J; Ziebarth NR; Schackman BR; Behrends CN
    J Gen Intern Med; 2021 Jul; 36(7):1898-1905. PubMed ID: 33469774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model.
    Fried JE; Basu S; Phillips RS; Landon BE
    Ann Fam Med; 2020 Nov; 18(6):535-544. PubMed ID: 33168682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients' experiences and preferences.
    Fox AD; Masyukova M; Cunningham CO
    Subst Abus; 2016; 37(1):70-5. PubMed ID: 26566712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "It's that longitudinal relationship that pays off": A qualitative study of internal medicine residents' perspectives on learning to prescribe buprenorphine.
    Logan AA; Jack HE; Darnton J; Klein JW
    Subst Abus; 2021; 42(4):944-950. PubMed ID: 33797320
    [No Abstract]   [Full Text] [Related]  

  • 9. Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
    Weiss L; Netherland J; Egan JE; Flanigan TP; Fiellin DA; Finkelstein R; Altice FL;
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S68-75. PubMed ID: 21317597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication between nurse care managers and patients who take opioids for chronic pain: Strategies for exploring aberrant behavior.
    Liebschutz JM; Lange AV; Heymann OD; Lasser KE; Corey P; Shanahan CW; Kopinski HS; Husain JM; Cushman PA; Parker VA
    J Opioid Manag; 2018; 14(3):191-202. PubMed ID: 30044484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.
    Tofighi B; Isaacs N; Byrnes-Enoch H; Lakew R; Lee JD; Berry C; Schatz D
    J Subst Abuse Treat; 2019 Nov; 106():1-3. PubMed ID: 31540604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
    D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
    J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment access for opioid use disorder in pregnancy among rural and American Indian communities.
    Kelley AT; Smid MC; Baylis JD; Charron E; Begaye LJ; Binns-Calvey A; Archer S; Weiner S; Pettey W; Cochran G
    J Subst Abuse Treat; 2022 May; 136():108685. PubMed ID: 34953636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic.
    Wakeman SE; McGovern S; Kehoe L; Kane MT; Powell EA; Casey SK; Yacorps GM; Irvin JR; Rodriguez W; Regan S
    J Subst Abuse Treat; 2022 Oct; 141():108848. PubMed ID: 35926256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "
    Checkley L; Steiger S; Knight KR
    Subst Abus; 2022; 43(1):767-773. PubMed ID: 35112998
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrating Buprenorphine Into an Opioid Treatment Program: Tailoring Care for Patients With Opioid Use Disorders.
    Polydorou S; Ross S; Coleman P; Duncan L; Roxas N; Thomas A; Mendoza S; Hansen H
    Psychiatr Serv; 2017 Mar; 68(3):295-298. PubMed ID: 27745534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.